Park West Asset Management LLC Has $45.15 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Park West Asset Management LLC trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 17.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,946,191 shares of the company’s stock after selling 414,987 shares during the period. Option Care Health makes up approximately 3.6% of Park West Asset Management LLC’s holdings, making the stock its 11th largest holding. Park West Asset Management LLC owned approximately 1.14% of Option Care Health worth $45,152,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. JPMorgan Chase & Co. grew its holdings in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company’s stock valued at $35,065,000 after buying an additional 344,875 shares during the period. Graypoint LLC bought a new stake in Option Care Health in the 4th quarter valued at approximately $1,161,000. Charles Schwab Investment Management Inc. boosted its position in Option Care Health by 6.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after acquiring an additional 147,054 shares during the last quarter. Global Alpha Capital Management Ltd. increased its stake in Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after buying an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Option Care Health in the fourth quarter valued at about $327,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Monday, April 21st. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $33.75.

Option Care Health Price Performance

Option Care Health stock opened at $32.97 on Tuesday. The stock’s 50 day moving average price is $33.37 and its two-hundred day moving average price is $28.78. The stock has a market capitalization of $5.42 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.36 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.36. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. On average, equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.